02037nam a2200481 i 4500001001300000003000600013005001700019007001400036008004100050040002800091042000800119043001200127050002100139074001600160086002000176099002000196110008200216245015700298264007100455300002300526336000800549337001600557338001900573490007700592500002400669500002100693500003600714500002500750504004100775533010600816610004100922610007000963650003901033650003601072650004501108650001401153650001401167655003401181776013101215776013201346810005801478999001901536on1062364004OCoLC20181217092328.0he bmb024bbca181109s2018    dcu     bb   f000 0 eng c  aGPObengerdacGPOdMvI  apcc  an-us--- 4aKF32b.E55 2018w  a1008-D (MF)0 aY 1.1/8:115-725  aY 1.1/8:115-7251 aUnited States.bCongress.bHouse.bCommittee on Energy and Commerce,eauthor.10aMedicaid Partnership Act :breport together with additional views (to accompany H.R. 5801) (including cost estimate of the Congressional Budget Office). 1a[Washington, D.C.] :b[U.S. Government Publishing Office],c[2018]  a37 pages ;c24 cm.  btxt  bh2rdamedia  bhe2rdacarrier1 aReport / 115th Congress, 2d session, House of Representatives ;v115-725  aTitle from caption.  a"June 12, 2018."  aShipping list no.: 2018-0192-M.  aCRDP Program record.  aIncludes bibliographical references.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2018]e1 microfiche : negative.10aUnited States.tSocial Security Act.10aUnited States.bFood and Drug AdministrationxRules and practice. 0aDrugsxPrescribingzUnited States. 0aDrug monitoringzUnited States. 0aOpioid abusezUnited StatesxPrevention. 0aMedicaid. 0aMedicare. 7aLegislative materials.2lcgft08iPrint version:aUnited States. Congress. House. Committee on Energy and Commerce.tMedicaid Partnership Actw(OCoLC)104208604808iOnline version:aUnited States. Congress. House. Committee on Energy and Commerce.tMedicaid Partnership Actw(OCoLC)10420750931 aUnited States.bCongress.bHouse.tReport ;v115-725.  c277165d277165